Hospi Corporation is a privately held, innovative medical device company committed to developing patient-centric products that optimize care.

Hospi is funded by investors with significant experience in the medical device and related industries. Leading investors in the company include: Thomas Fogarty, Richard Kashnow, Paul Robbins, Oscar Schafer and Wilson Sonsini Goodrich & Rosati.

Hospi supporters see potential growth for the company given its focus on practical, high impact medical devices that enhance patient comfort and wellbeing, ease caregiver burden, and reduce cost.

“I was drawn to Hospi’s determination to commercialize the Macy Catheter, a product that aims to bring comfort to patients with unmet needs. The thoughtful, cost-effective approach this young company is taking is consistent with our societal goal of improving health care while reducing costs. I like the idea of investing in a new company that will generate good financial returns while providing something of immediate value to a large class of patients.”
Richard A. Kashnow, Ph.D.
Retired Chairman and CEO, Raychem
“In my years as a physician at Laguna Honda Hospital in San Francisco, patients residing in the in-house hospice and indeed, other residents, were in constant need for more facile and humane means to deliver critical medications. Hospi has chosen to focus its innovation on this very segment of the patient population. The company’s first product elegantly formalizes a simple but powerful concept of delivering medications via a route that ensures fast and reliable absorption. I look forward to the appearance of new products that fill comparable voids.”
Hugh Y. Rienhoff, Jr., M.D.
San Francisco, California